ShRNA Screening and Histopathology

ShRNA 筛选和组织病理学

基本信息

  • 批准号:
    280454646
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    德国
  • 项目类别:
    Research Units
  • 财政年份:
    2015
  • 资助国家:
    德国
  • 起止时间:
    2014-12-31 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

This central project provides critical technologies to this research consortium. Specifically, Z01 has three tasks:First, this project provides the synthesis of focused shRNA libraries and and the analysis of screens with these libraries. In particular, the project provides focused shRNA libraries as well as technical advice for both in vitro and in vivo shRNA screens, advises individual projects on set-up of in vivo experiments (e.g. animal number), and recovers and sequences the genomic DNA containing the retroviral inserts. The project also analyses the sequencing data including a statistical analysis. As part of this service, the Z01 also handles all communication with Mirimus and the handling of shRNA-transgenic mice that are imported into the consortium. The second task of this project is the target validation using a pipeline of established stress assays. This part involves the analysis of multiple stress parameters after depletion of specific targets or interference with small molecules using high-content microscopy and optical image analysis. These assays are established and data are provided as quantitative evaluation to all members of this consortium. This screening core facility will also perform small molecule screens of FDA-approved compounds in the next funding period. The third task of this project is to provide mouse and human pathology analyses with the aim to validate therapeutic targets (e.g. by analyzing their expression in human tumors) and to study the in vivo effects of interfering with essential processes in tumors. In the next funding period, this part of the project will include a standardized analysis of immune cell infiltrates into tumors after therapeutic intervention. This analysis pipeline and the necessary staining protocols have been established.
该中心项目为该研究联盟提供关键技术。具体来说,Z01有三个任务:首先,该项目提供了聚焦shRNA文库的合成和这些文库的筛选分析。特别是,该项目提供了集中的shRNA文库以及体外和体内shRNA筛选的技术建议,就体内实验的设置(例如动物编号)为各个项目提供建议,并回收和测序含有逆转录病毒插入物的基因组DNA。该项目还分析了测序数据,包括统计分析。作为这项服务的一部分,Z01还处理与Mirimus的所有通信,以及处理进口到联盟中的shRNA转基因小鼠。该项目的第二项任务是使用已建立的压力测定管道进行目标验证。本部分涉及使用高含量显微镜和光学图像分析对特定靶标耗竭或小分子干扰后的多个应力参数进行分析。建立了这些测定法,并向该联合体的所有成员提供数据作为定量评价。该筛选核心设施还将在下一个资助期内对FDA批准的化合物进行小分子筛选。该项目的第三个任务是提供小鼠和人类病理学分析,目的是验证治疗靶点(例如通过分析其在人类肿瘤中的表达),并研究干扰肿瘤基本过程的体内效应。在下一个资助期内,该项目的这一部分将包括治疗干预后免疫细胞浸润到肿瘤中的标准化分析。该分析管道和必要的染色方案已经建立。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Martin Eilers其他文献

Professor Dr. Martin Eilers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Martin Eilers', 18)}}的其他基金

Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands
通过 Aurora-A 配体靶向 MYC 驱动的肝细胞癌
  • 批准号:
    409494652
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Units
Targeting MYC in pancreatic cancer
靶向 MYC 治疗胰腺癌
  • 批准号:
    280452953
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
    Research Units
Systematic shRNA screens for the analysis of critical signaling pathways in KRAS-mutant multiple myeloma
系统性 shRNA 筛选分析 KRAS 突变型多发性骨髓瘤的关键信号通路
  • 批准号:
    242271643
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Clinical Research Units
Myc-dependent apoptosis as a tumor-suppressive mechanism: how do cells discriminate between physiological and oncogenic levels of Myc expression?
Myc 依赖性细胞凋亡作为肿瘤抑制机制:细胞如何区分 Myc 表达的生理水平和致癌水平?
  • 批准号:
    244461114
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Systemic shRNA screens and high throughout sequencing to investigate pathway dependence in multiple myeloma
系统 shRNA 筛选和高通量测序以研究多发性骨髓瘤的通路依赖性
  • 批准号:
    144856378
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Clinical Research Units
Systematic shRNA and siRNA screens to investigate drug resistance in human leukemia
系统性 shRNA 和 siRNA 筛选研究人类白血病的耐药性
  • 批准号:
    81569355
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
    Clinical Research Units
Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
Miz1 在 Atr/Chk1 信号通路和 Myc 诱导的细胞凋亡中的作用
  • 批准号:
    5422428
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Research Units
Rolle des Zink-Finger-Proteins Miz-1 in der Tumorigenese und in der Kontrolle der Proliferation von Keratinozyten und Lymphozyten
锌指蛋白 Miz-1 在肿瘤发生以及角质形成细胞和淋巴细胞增殖控制中的作用
  • 批准号:
    5340710
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Regulation of the cdk inhibitor, p27 Regulation des cdk inhibitor, p27
cdk 抑制剂的调节,第 27 页 cdk 抑制剂的调节,第 27 页
  • 批准号:
    5224632
  • 财政年份:
    1995
  • 资助金额:
    --
  • 项目类别:
    Priority Programmes
MYCN-dependent Transcription Termination and Stress Resilience of Transcription
MYCN依赖性转录终止和转录的应激恢复能力
  • 批准号:
    438596161
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

基于Safe screening的多任务稀疏学习理论与算法的研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
基于Safe screening 的支持向量机的稀疏理论及其快速求解方法
  • 批准号:
    11671010
  • 批准年份:
    2016
  • 资助金额:
    48.0 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating the acceptability and accuracy of cervical screening and self-sampling in postnatal women to coincide with the 6-week postnatal check-up
调查产后妇女进行宫颈筛查和自我采样以配合产后 6 周检查的可接受性和准确性
  • 批准号:
    MR/X030776/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Expanding syphilis screening among pregnant women in Indonesia using the rapid dual test for syphilis & HIV with capacity building: The DUALIS Study
使用梅毒快速双重检测扩大印度尼西亚孕妇梅毒筛查
  • 批准号:
    MR/Y004825/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Screen4SpLDs - Development of an Automated Pre-Screening Tool for Specific Learning Disabilities in Children.
Screen4SpLDs - 开发针对儿童特定学习障碍的自动预筛查工具。
  • 批准号:
    EP/Y002121/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
RII Track-4:NSF: Integrated Electrochemical-Optical Microscopy for High Throughput Screening of Electrocatalysts
RII Track-4:NSF:用于高通量筛选电催化剂的集成电化学光学显微镜
  • 批准号:
    2327025
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
  • 批准号:
    2332121
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Cooperative Agreement
New, easy to use, low-cost technologies based on DNA origami biosensing to achieve distributed screening for AMR and improved antibiotic prescribing
基于 DNA 折纸生物传感的易于使用、低成本的新型技术,可实现 AMR 的分布式筛查并改进抗生素处方
  • 批准号:
    MR/Y034481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Screening of environmentally friendly quantum-nanocrystals for energy and bioimaging applications by combining experiment and theory with machine learning
通过将实验和理论与机器学习相结合,筛选用于能源和生物成像应用的环保量子纳米晶体
  • 批准号:
    23K20272
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Creating an intracellular screening platform for cyclic peptide drug discovery
创建用于环肽药物发现的细胞内筛选平台
  • 批准号:
    EP/Z533002/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Healthy Jozi: A Staged Approach to Better Workplace Food Choices and Chronic Disease Screening and Linkage to Care
健康 Jozi:更好的工作场所食物选择和慢性病筛查以及与护理联系的分阶段方法
  • 批准号:
    MR/Z000467/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了